作者: Todd M. Tuttle , Steven A. Curley , Mark S. Roh
DOI: 10.1007/BF02303794
关键词: Surgery 、 Recurrent disease 、 General surgery 、 Hepatic resection 、 Surgical oncology 、 Repeat hepatectomy 、 Medicine 、 Survival benefit 、 Effective treatment 、 Resection
摘要: Background: Approximately 20–40% of patients who undergo liver resection for colorectal metastases develop recurrent disease confined to the liver. The goals this study were determine whether survival benefit repeat hepatic justified potential morbidity and mortality.